Publicaciones en las que colabora con CRISTINA BLÁZQUEZ ORTIZ (36)

2024

  1. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

2023

  1. Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling

    Cancers, Vol. 15, Núm. 9

2020

  1. Cannabinoid-induced motor dysfunction via autophagy inhibition

    Autophagy, Vol. 16, Núm. 12, pp. 2289-2291

  2. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination

    eLife, Vol. 9, pp. 1-24

2016

  1. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

    Neuropharmacology, Vol. 108, pp. 345-352

  2. Sustained Gq-protein signaling disrupts striatal circuits via JNK

    Journal of Neuroscience, Vol. 36, Núm. 41, pp. 10611-10624

2015

  1. The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway

    Cell Death and Differentiation, Vol. 22, Núm. 10, pp. 1618-1629

2014

  1. A restricted population of CB1 cannabinoid receptors with neuroprotective activity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262

2011

  1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136

  2. Reply: Reliability of immunolabelling in the determination of Huntington's disease neuropathy

    Brain

2010

  1. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner

    Cardiovascular Research, Vol. 85, Núm. 1, pp. 56-67

2009

  1. Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis

    GLIA, Vol. 57, Núm. 13, pp. 1374-1385

  2. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells

    Journal of Clinical Investigation, Vol. 119, Núm. 5, pp. 1359-1372

2008

  1. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression

    Cancer Research, Vol. 68, Núm. 6, pp. 1945-1952

  2. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?

    Neuropharmacology, Vol. 54, Núm. 1, pp. 235-243

  3. Targeting cannabinoid receptors in brain tumors

    Cannabinoids and the Brain (Springer US), pp. 361-374

2007

  1. Cannabinoids and gliomas

    Molecular Neurobiology, Vol. 36, Núm. 1, pp. 60-67

2006

  1. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells

    Molecular Pharmacology, Vol. 70, Núm. 1, pp. 51-59

  2. A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

    British Journal of Cancer, Vol. 95, Núm. 2, pp. 197-203

  3. Cannabinoid receptors as novel targets for the treatment of melanoma

    FASEB Journal, Vol. 20, Núm. 14